Skip to main content
Andrew Farach, MD, Radiation Oncology, Houston, TX

AndrewFarachMD

Radiation Oncology • Houston, TX

Gastrointestinal Cancer, Gynecologic Cancer, Thoracic Cancer

Director of Brachytherapy

Join to view full profile

Dr. Farach is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Farach's full profile

Already have an account?

  • Office

    6565 Fannin Street
    DB 1-077
    Houston, TX 77030
    Phone+1 713-441-4800
    Fax+1 713-793-1300

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineChief Residency, Radiation Oncology, 2014 - 2015
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Radiation Oncology, 2011 - 2015
  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Transitional Year, 2010 - 2011
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2010

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2015 - 2025
  • American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Press Mentions

  • UTHealth Closes Child Care Center Serving Health Care Workers’ Families
    UTHealth Closes Child Care Center Serving Health Care Workers’ FamiliesApril 30th, 2020
  • NSCLC Treatment Utilization, Survival Rates Hindered by Racial Disparities
    NSCLC Treatment Utilization, Survival Rates Hindered by Racial DisparitiesApril 14th, 2017
  • Widespread Adoption of SBRT Has Improved Survival Rates for Elderly Patients with Early Stage Lung Cancer
    Widespread Adoption of SBRT Has Improved Survival Rates for Elderly Patients with Early Stage Lung CancerDecember 10th, 2016
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish

Dr. Andrew Farach, Dr. Andrew Farach, MD, Dr. A Farach